About Index Trending news
Analyze
Top 50 Pricing
Ablynx

Ablynx

Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of NanobodiesĀ® for a range of serious human diseases.

Elsewhere

Alexa global traffic share

Twitter followers

13 Aug 2014
$2,808,275
Grant
30 Jun 2014
$56,972,661
Post-IPO equity